NEW YORK (MarketWatch) -- Medtronic Inc. (MDT) said Monday that it has resolved all outstanding intellectual-property litigation with Abbott Laboratories (ABT). As part of the agreement, Medtronic will pay $400 milion to Abbott and $42 million to evYsio...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Medtronic, Abbott settle patent litigation
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account